, médicaments et accroître l'accès à ceux-ci". Cette résolution est vraisemblablement une application directe des recommandations du

V. I. Bibliographiques,

S. Chauveau, invention pharmaceutique: la pharmacie française entre l'État et la société au XXe siècle. Sanofi-Synthelabo, vol.720, 1999.

J. Neukirch, La fonction commerciale dans l'industrie pharmaceutique. Labo-Pharma, 1956.

, An innovative approach to R&D for neglected patients: Ten years of experience and lessons learnt by DNDi, 2012.

, Débats parlementaires, 1946.

R. J. Sante-publique, Ordonnance, 1756.

, Histoire des Nations Unies, vol.21

, Histoire des Nations Unies, vol.21, 2014.

. Oms-|-histoire-de-l'oms, World Health Organization; 1 sept, 2016.

. Disponible,

, OMS: ses principes. World Health Organization; 1 sept, 2016.

. Oms-|-ce-que-nous and . Faisons, World Health Organization; 1 sept, 2016.

. Oms-|-gouvernance-de-l'oms, World Health Organization; 1 sept, 2017.

C. Correa and G. Velasquez, L'accès aux médicaments: Entre le droit à la santé et les nouvelles règles de commerce international

, OMC | Accords commerciaux r?gionaux: -Les r?gles fondamentales

, OMC | Textes juridiques -Acte Final

, OMC | Comprendre l'omc -accords aper?u g?n?ral

. Disponible,

. Omc-|-textes-juridiques--accord-de-marrakech and I. V. Partie, Commerce et Développement

. Qu, est-ce que la propriété intellectuelle?

. Omc-|-propri?t?-intellectuelle, ADPIC)

. Omc-|-propri?t?-intellectuelle--annexe-1c,

. Omc-|-propri?t?-intellectuelle, ADPIC) -texte de l'Accord -Dispositions g?n?rales et principes fondamentaux

P. Benkimoun and . Préface, L'Harmattan, rédacteur. L'accès aux médicaments, vol.26, 2010.

. Omc-|-propri?t?-intellectuelle, ADPIC) -texte de l'Accord -Dispositions g?n?rales et principes fondamentaux

I. I. Omc-|-propri?t?-intellectuelle--partie, Normes concernant l'existence, la port?e et l'exercise des droits de propriete intellectuelle

. Disponible,

E. ,

. Ircam, 'importation parallèle

-. Omc-|-propri?t?-intellectuelle and . Vi, DISPOSITIONS TRANSITOIRES

. Mpp-arv-patenting-trends-final2, , 2018.

I. I. Omc-|-propri?t?-intellectuelle--partie, Normes concernant l'existence, la port?e et l'exercise des droits de propriete intellectuelle

. Disponible,

. Omc-|-propri?t?-intellectuelle, ADPIC) -texte de l'Accord -Dispositions g?n?rales et principes fondamentaux

C. Correa, The Uruguay Round and Drugs. WHO Task Force On Health Economics, 1997.

, OMC | Conf?rences minist?rielles -Doha 2001 -ADPIC

, Traités administrés par l'OMPI: Convention de Paris pour la protection de la propriété industrielle

C. Correa and G. Velasquez, Comment préserver l'accès aux médicaments: Innovation pharmaceutique et santé publique. Editions L'Harmattan, vol.186, 2010.

, OMC | Conf?rences minist?rielles -Doha 2001 -D?claration minist?rielle

G. Velásquez and P. Boulet, Essential drugs in the new international economic environment, Bull World Health Organ, vol.77, issue.3, pp.288-92, 1999.

G. Velásquez, P. Hanvoravongchai, and P. Boulet, Globalization, Patents and Drugs: An Annotated Bibliography, vol.52, 2001.

E. Hoen, The Declaration on TRIPS and Public Health: A step in the Right Direction. Bridges [En ligne, vol.9, 2001.

. Ip/c/w/340,

H. E. Kettler, Using Intellectual Property Regimes to Meet Global Health R&D Needs, J World Intellect Prop, vol.5, issue.5, pp.655-83, 2005.

. Omc-|-propriété-intellectuelle, ADPIC) -texte de l'Accord -Dispositions g?n?rales et principes fondamentaux

I. I. Omc-|-propriété-intellectuelle--partie, Normes concernant l'existence, la portée et l'exercise des droits de propriete intellectuelle

. Disponible,

. Disponible,

P. Au-commerce-cdadd-de, . Mise, L. Oeuvre-de-l'article-;-de-l'accord-sur, and . Adpic, , vol.66

I. I. Omc-|-propriété-intellectuelle--partie, Normes concernant l'existence, la port?e et l'exercise des droits de propriete intellectuelle

. Disponible,

I. I. Omc-|-propriété-intellectuelle--partie, Normes concernant l'existence, la portée et l'exercise des droits de propriete intellectuelle

. Disponible,

I. I. Omc-|-propriété-intellectuelle--partie, Normes concernant l'existence, la portée et l'exercise des droits de propriete intellectuelle

. Disponible,

, OMC | Propriété intellectuelle -Mise enoe uvre du paragraphe 6 de la déclaration de Doha

. Omc-|-propriété-intellectuelle--adpic,

. Omc-|-nouvelles, Modification des règles de l'OMC en matière de propriété intellectuelle afin de faciliter l'accès des pays pauvres à des médicaments abordables, 2017.

, Santé publique, innovation et droits de propriété intellectuelle : rapport de la Commission sur les Droits de la Propriété intellectuelle, l'Innovation et la Santé publique, de la propriété intellectuelle l'innovation et la Santé Publique CSLD, 2006.

, Santé publique, innovation et droits de propriété intellectuelle Rapport de la Commission sur les Droits de la Propriété intellectuelle, l'Innovation et la Santé publique

. Wha61, Global strategy and plan of action on public health, innovation and intellectual property

W. Data, Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. WHO, 2011.

. Ewg, Santé publique, innovation et propriété intellectuelle : Stratégie mondiale et Plan d'action Rapport du groupe de travail d'experts sur le financement de la recherchedéveloppement. WHA63, vol.2010

. Wha-a68/, Public health, innovation and intellectual property: global strategy and plan of action Report of the Expert Working Group on Research and Development Financing, OMS

, Constitution d'un groupe de travail consultatif d'experts sur le financement et la coordination de la recherche-développement. Soixante-Troisième Assemblée mondiale de la Santé, p.60

C. Stein, Consultative Expert Working Group on Research and Development (CEWG): financing and coordination

S. Oms, Open-ended meeting of Member States to assess progress and continue discussions on the remaining issues in relation to monitoring, coordination and financing for health research and development Provisional agenda item 5. OMS, vol.2016

, The Process, High-Level Panel on Access to Medicines

. Disponible,

E. Said, &. Kapczynski, and M. , Access to medicines: The role of intellectual property law and policy. Global Commission on HIV and the law, vol.7, 2011.

, Lancement de la Commission mondiale sur le VIH et le droit : « Remédier aux lois punitives et aux violations des droits de l'homme qui entravent l'efficacité des réponses au SIDA ». Programme des Nations Unies pour le développement (PNUD)

, transformer nos vies et protéger la planète Rapport de synthèse du Secrétaire général sur le programme de développement durable pour l'après-2015. 4 déc 2014;69e session de l'Assemblée générale des Nations Unies, des Nations Unies SG. La dignité pour tous d'ici à 2030 : éliminer la pauvreté

, Report of the United Nations Secretary-General's High-Levee Panel on Acces to Medicines -Promoting innovation and access to health technologies, UNHLP

, Invitation à soumettre des contributions, UNHLP, 2016.

, Global Dialogue live from London, UNHLP, 2016.

, Private Patents and Public Health

, UNHLP. Global Dialogue live from Johannesburg

, Médicaments biosimilaires -Point d'information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

, HCDH | Pacte international relatif aux droits économiques, sociaux et culturels, vol.232, 2016.

J. Raftery, Should NICE's threshold range for cost per QALY be raised? No, BMJ. 26 janv, vol.338, p.185, 2009.

]. En-ligne and . Website,

, Intellectual Property Watch

W. New, Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec -Intellectual Property Watch, vol.6

, Intellectual Property Watch

W. New and . Damaging, Provisions On IP Dropped From TPP Agreement, MSF Says -Intellectual Property Watch, vol.15, 2017.

]. En-ligne and . Andre, IBSA Trilateral -HOME

B. Pharmaceutical, Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance, 2016.

. Oms-|-médicaments-essentiels, World Health Organization, vol.23

. Oms-|-l, OMS met à jour sa liste des médicaments essentiels avec de nouvelles recommandations sur l'utilisation des antibiotiques, World Health Organization, vol.1, issue.2017

, Clinton Health Acces Initiative. ARV MARKET REPORT

H. and M. K. , Ensuring that essential medicines are also affordable medicines: challenges and options. Organisation Mondiale de la Santé, Clinton Health Acces Initiative, 2016.

S. M. Paul, D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos et al., How to improve R&D productivity: the pharmaceutical industry's grand challenge, Nat Rev Drug Discov, vol.9, issue.3, pp.203-217, 2010.

, Gilead s'offre Pharmasset pour 11 milliards de dollars, vol.21, 2011.

. Investir,

, OPA amicale sur Pharmasset pour USD10,4 milliards, vol.21, 2011.

. Gavi, the Vaccine Alliance

, Infographic: The Impact of Advance Market Commitment

, Advance Market Commitment

, WIPO. PATENT POOLS AND ANTITRUST -A COMPARATIVE ANALYSIS

. Wipo;-mars, , 2014.

, The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment, MPP, 2015.

C. De-luca, Medicine patent pool--pharma philanthropy or PR?, Expert Opin Ther Pat. 3 août, vol.25, issue.11, pp.1223-1230, 2015.

]. En-ligne and . Melsgac, Medicines Patent Pool, vol.5

. Disponible,

, About Us -Open Source Drug Discovery

G. A. Hodge and C. Greve, Public?Private Partnerships: An International Performance Review, Public Adm Rev. mai, vol.67, issue.3, pp.545-58, 2007.

R. Ramamoorthi, K. M. Graef, J. Dent, and . Wipo-re, Search: Accelerating anthelmintic development through cross-sector partnerships, Int J Parasitol Drugs Drug Resist. déc, vol.4, issue.3, pp.220-225, 2014.

, United States Department of State, High-Level Panel on Access to Medicines

H. Grant, UN calls on big pharma to reduce cost of life-saving medicines, vol.14

T. J. Philipson, Economic Nonsense From the U.N. on Drugs. WSJ Online

, FMF statement on the UN High Level Panel on Innovation and Access to Health Technologies

, New UN Recommendations on Access to Medicines Will Have Exact Opposite of Intended Effect

, Cheap drugs for everyone sounds nice, but who would make them?, vol.28

, The United Nations Report on Access to Medicines is a Public Health Hazard | RealClearHealth, 2018.

C. Post,

B. Gossett, Protect patents around the world, vol.20

, UN Report Calls for Breaking Link Between Drug R&D Costs and Prices | RAPS

, Pharmaceutical Access in Least Developed Countries: On-the-Ground Barriers and Industry Successes

J. D. Alpern, J. Song, and W. M. Stauffer, Essential Medicines in the United States -Why Access Is Diminishing, N Engl J Med, vol.374, issue.20, pp.1904-1911, 2016.

. Shopfloor,

L. Dempsey, Lose-Lose Proposal from UNHLP Panel Represents a Missed Opportunity and Poses a Real Threat -Shopfloor, vol.14

T. Patents and C. ,

, Intellectual Property Watch

, A Price Too Good To Be True -Intellectual Property Watch, vol.26

, Intellectual Property Watch

C. Saez and . High, Level Panel On Access To Medicines Issues « Landmark, vol.14

, Access to medicines-the status quo is no longer an option, The Lancet, Lancet T, vol.388, p.1250, 2016.

. Tac--treatment, Action Campaign -Campaign for access to AIDS treatment

, MSF Statement on Political Declaration of the United Nations General Assembly High-Level Meeting on Antimicrobial Resistance

. Disponible,

, PATH Statement on the United Nations Secretary-General's High-Level Panel on Access to Medicines Report

, DNDi response to the Report of the United Nations Secretary-General's High-Level Panel on Access to Medicines -Page 4 -DNDi

. Disponible,

, UN High-Level Panel Says Trade Agreements Such As TPP Threaten Public Health AND Human Rights -Canadian HIV/AIDS Legal Network

, Media Statement: Health Action International Response to Report by UN High-level Panel on Access to Medicines -Health Action International, Health Action International

M. Kamal-yanni, Report of the UN Secretary-General's High-Level Panel on human rights and medicines: Oxfam's response. Oxfam; 14 sept, 2016.

. Disponible,

T. Vollmer, United Nations Report Calls for Open Access to Research to Improve Global Health -Creative Commons, vol.6, 2016.

, The Irish Times

T. I. Times, Held to ransom by drug companies?; 4 mars, 2017.

C. Saez, Things Heat Up In WIPO Debate On Patents And Health -Intellectual Property Watch, vol.14

. Disponible,

, Technologies Essential for Human Wellbeing, Secretary-General Says, Encouraging Compliance with Health Panel's Findings | Meetings Coverage and Press Releases

U. Conference, , vol.15

W. Wipo and . Joint, Symposium on Antimicrobial Resistance: How to Foster Innovation, Access and Appropriate Use of Antibiotics?

, Universities Allied for Essential Medicines

, Press Releases & Statements by UAEM -Universities Allied for Essential Medicines

, Proposals undermining innovators won't help India: US Chambers of Commerce, The Economic Times, vol.22, 2016.

O. Bureau, India to US: Will not tighten IPR rules beyond TRIPS mandate, vol.16

J. Cone, R. C. Offenheiser, and U. S. The, Is Standing in the Way of Cheaper Drugs for the Poor, NY Times, 2016.

, Intellectual Property Watch

W. New, . Us, and . Business, Government Work To Bring Down « Dangerous » UN Panel Report On Access To Medicines -And Change The Debate In Geneva -Intellectual Property Watch, vol.23

. Disponible,

V. U. Krishnan, nixed India's plea on reforms in medicine, vol.3

, The battle to access affordable medicines heats up, vol.17

, EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines, vol.23

, Intellectual Property Watch

C. Saez, . Who, and . Board, UN Report On Medicines Too Hot; DG Candidates To Be Narrowed -Intellectual Property Watch, vol.23

, WHO | Address to the Executive Board at its 140th session. World Health Organization, vol.23

. Disponible,

. Sangeeta-shashikant, World Health Assembly to Discuss UN High Level Report on Access to Medicines, vol.2, issue.2016

. Disponible,

W. New, . Who, and . Board, Discuss UN HighLevel Panel Report On Medicines Access -Intellectual Property Watch, 2016.

, Make Medicines Affordable

O. Letter, . Who-director, M. General, and . Chan, , vol.9, 2016.

M. J. Barber, D. Gotham, J. Muntanyà, and T. Balasubramaniam, Open letter to the candidates for Director-General of WHO: will you support a patient-centred R&D agreement? The Lancet Global Health, vol.5, pp.135-141, 2017.

, Intellectual Property Watch

C. Saez and . Ip, And The Public Interest Premieres At WTO TRIPS Council Next Week -Intellectual Property Watch, vol.7

. Kei, . Wto, and C. Council--brazil, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines, vol.31, 2016.

, -WTO TRIPS Council -Brazil's intervention on the Report of the UN High-Level Panel on Access to Medicines, vol.10, 2016.

, -WTO TRIPS Council -WHO's intervention on the Report of the UN High-Level Panel on Access to Medicines, vol.10, 2016.

, -WTO TRIPS Council -EU's intervention on the Report of the UN High-Level Panel on Access to Medicines, vol.11, 2016.

, Intellectual Property Watch

C. Saez, Main Recommendations Of UN HighLevel Panel On Access To Medicines Presented At WTO -Intellectual Property Watch, vol.7

, EEAS -European External Action Service

, WIPO Standing Committee on Law of Patents 25th session -Patents and Health -EEAS -European External Action Service -European Commission, vol.16

, SCP25: Statement of Asia Pacific Group on Patents and Health, vol.13

, SCP25: Statement of the Republic of South Africa on Patents and Health, vol.13

, Intellectual Property Watch

C. Saez, Patents And Health Debate Brings Key WIPO Committee To Standstill -Intellectual Property Watch, vol.16

, PCB39: Statement of Knowledge Ecology International on Agenda item 6: UNAIDS synthesis report on IP, vol.7

, Human Rights Council's Access to Medicines panel set to discuss Report of UN HLP; 4 mars, 2017.

, MSF statement at Human Rights Council panel discussion on the UN Secretary-General's High-Level Panel on Access to Medicines

. Disponible,

, United Nations Web TV

, Panel Discussion on Access to Medicines -24th

, Meeting, 34th Regular Session Human Rights Council

, Intellectual Property Watch

C. Saez, Access To Medicines Resolution Adopted By UN Human Rights Council -Intellectual Property Watch, vol.1

, Intellectual Property Watch

C. Saez and . High, Level Panel On Access To Medicines Takes Next Step At Human Rights Council -Intellectual Property Watch, vol.9, 2017.

W. D. Ltd and . Holy-see, Universal access to medicine is a moral obligation | ICN

, HRC35: Human Rights Council adopts Right to Health Resolution, vol.22

, Intellectual Property Watch

W. New, The Case For Nations To Act On Medicines Access -Intellectual Property Watch, vol.23

. Disponible,

L. Ploumen and E. Schippers, Better life through medicine-let's leave no one behind, Lancet, vol.389, pp.339-380, 2017.

, Technologies Essential for Human Wellbeing, Secretary-General Says, Encouraging Compliance with Health Panel's Findings | Meetings Coverage and Press Releases

, Intellectual Property Watch

W. New and . Secretary, General Urges Action On High-Level Panel Report On Medicines Access -Intellectual Property Watch, vol.22, 2016.

S. Moon, Powerful Ideas for Global Access to Medicines, N Engl J Med. 9 févr, vol.376, issue.6, pp.505-512, 2017.

, Nikkei Asian Review

, to freeze drug data protection demanded by US-Nikkei Asian Review, vol.31

, Knowledge Ecology International

A. Goldman, Chilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents, vol.25

, Annexes Annexe n°1 : Déclaration de Doha sur l'accord sur les ADPIC et la santé publique a) Demandes de licences obligatoires entre 2001 et 2014. Extrait de Private patents and public health, Health Action International, issue.78, 2016.